Dr. Blute on Kidney-Sparing Surgery Vs Radical Nephrectomy in RCC

Video

Michael L. Blute, MD, chair of Department of Urology, Massachusetts General Hospital, discusses the differences between kidney-sparing surgery and radical nephrectomy for patients with renal cell carcinoma (RCC).

Michael L. Blute, MD, chair of the Department of Urology, Massachusetts General Hospital, discusses the differences between kidney-sparing surgery and radical nephrectomy for patients with renal cell carcinoma (RCC).

It is important to identify the appropriate criteria for which patients can undergo nephrectomy or kidney-sparing surgery for their disease, Blute explains. However, until more information is available, treatments will need to be individualized based on a patient's comorbidities, age, and current kidney function to inform practitioners which procedure would be more beneficial for patients.

There has been a paradigm shift that urologists are facing in order to avoid chronic kidney disease in patients, he adds. The rates of partial nephrectomy for small renal masses, for example, have been doubled.

Related Videos
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,
Guenther Koehne, MD, PhD
Alessandro Villa, DDS, PhD, MPH
Joseph Mikhael, MD
Michael Richardson, MD
Minesh Mehta, MD
Ruben Olivares, MD
Phillip J. Koo, MD